Today: 21 July 2026
Browse Category

NYSE:UNH 8 January 2026 - 18 January 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

U.S. healthcare stocks wrapped up the week as the S&P 500’s weakest sector, with the Health Care Select Sector SPDR Fund slipping 0.8% on Friday to $155.74. Anthony Saglimbene, chief market strategist at Ameriprise Financial, noted that “most investors will take that as a win,” given the market hovered near record highs despite a volatile week.
17 January 2026
······
Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

The Dow Jones Industrial Average dipped in early Friday trading, erasing a modest gain from the open as declines in healthcare and consumer sectors weighed on the index. Around 10 a.m. ET, the Dow was down 70.37 points, or 0.14%, at 49,372.07. The S&P 500 edged up 0.07%, while the Nasdaq Composite climbed 0.26%. Among the Dow's biggest losers were Salesforce, Merck, and UnitedHealth, with Nvidia bucking the trend and moving higher.
16 January 2026
········
UnitedHealth stock slides after Senate report targets Medicare Advantage coding as UNH earnings loom

UnitedHealth stock slides after Senate report targets Medicare Advantage coding as UNH earnings loom

Shares of UnitedHealth Group Incorporated dropped roughly 1.3%, hitting $336.10 by midday Tuesday. The move came after a Senate Judiciary Committee report criticized the insurer’s Medicare Advantage risk-adjustment coding. Senator Chuck Grassley, who chairs the panel, claimed the company “appears to be gaming the system” related to payments for sicker patients.
13 January 2026
··
UnitedHealth (UNH) stock falls on Senate Medicare report as earnings near

UnitedHealth (UNH) stock falls on Senate Medicare report as earnings near

Shares of UnitedHealth Group dropped Monday following a U.S. Senate committee report accusing the insurer of using aggressive risk-adjustment coding to increase Medicare Advantage payments. The stock closed down nearly 2% at $337.15, then edged up about 1% to $340.51 in after-hours trading. The report intensifies scrutiny of UnitedHealth’s Medicare billing practices, coming after the company disclosed last year it was cooperating with U.S. Justice Department inquiries.
13 January 2026
··
UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

Shares of UnitedHealth Group Incorporated slipped 0.8% on Friday, ending the session at $343.98. The drop came amid heightened scrutiny from U.S. lawmakers targeting the company’s nursing-home programs. Senators Elizabeth Warren and Ron Wyden said they’re broadening their investigation after deeming the insurer’s response inadequate, and warned they would deploy “all tools” at their disposal if UnitedHealth fails to fully cooperate.
10 January 2026
··
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House lawmakers have called on UnitedHealth Group Incorporated and four other major insurers to testify on coverage affordability later this month, signaling growing Washington scrutiny. UnitedHealth shares rose 1.5% to close at $346.85 on Thursday. The House Energy and Commerce Committee and the Ways and Means Committee extended invitations to UnitedHealth, CVS Health, Cigna, Elevance and Ascendia for testimony on Jan. 22. Reuters
9 January 2026
·····
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated shares rose on Thursday after U.S. House lawmakers invited the CEOs of major health insurers to testify on January 22 about coverage affordability, as Republicans debate whether to extend Affordable Care Act subsidies and President Donald Trump has said he plans to meet insurers. The stock was up 1.3% at $346.11 by early afternoon, after trading between $339.99 and $347.79. CVS Health, Cigna and Elevance Health, also named for the hearing, were higher. Reuters
8 January 2026
····
1 … 4 5 6 7 8 … 11
Go toTop